Pharmacosmos sponsor at ESPHM 2017

March 20, 2017

Pharmacosmos has signed up as sponsor at the 9th European Symposium of Porcine Health Management. in Prague/Czech Republic - from the 3rd - 5th of May 2017.

We welcome new and existing Uniferon customers to visit our exhibition where we would be pleased to inform you about Uniferon and discuss optimized anaemia care.

Visit us at our Exhibition stand S5. Find the position on the image below.

For additional information about ESPHM 2017, please visit:

Click to enlarge

About Uniferon

Uniferon 200 is an iron supplement that adds value to your business by promoting better health and faster growth in your piglets. Manufactured by Pharmacosmos, Uniferon 200 combines the benefits of simple, fast administration with all-natural, high efficacy ingredients.

Pharmacosmos is dedicated to developing and marketing industry-leading iron deficiency treatments for both humans and animals. We focus on improving treatment options by staying on top of industry best practices. A privately-owned company with an extensive network of partners, Pharmacosmos operates in more than 50 countries across Europe, the Americas and Asia.

About Pharmacosmos

Headquartered in Denmark, Pharmacosmos is a family-owned, international healthcare company with more than 50 years of innovation and leadership in iron- and carbohydrate-based treatments and solutions for human and animal use.

A research-based company, its ongoing R&D programme focuses on improving the lives of patients with iron deficiency with or without anaemia. More than 1 billion people live with iron deficiency anaemia and it is the leading cause of death for an estimated 180,000 people every year. This makes it one of the largest global health challenges of our time.

Pharmacosmos has subsidiaries in the Nordics, the UK and the US and its products are marketed in more than 80 countries across the world. Its manufacturing facilities are approved, among others, by the Danish Medicines Agency and the US FDA.